HIMS
Price
$24.40
Change
-$1.14 (-4.46%)
Updated
Feb 4 closing price
Capitalization
5.55B
18 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$14.71
Change
+$0.57 (+4.03%)
Updated
Feb 4 closing price
Capitalization
2.02B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HIMS vs PRGO

Header iconHIMS vs PRGO Comparison
Open Charts HIMS vs PRGOBanner chart's image
Hims & Hers Health
Price$24.40
Change-$1.14 (-4.46%)
Volume$31.68M
Capitalization5.55B
Perrigo
Price$14.71
Change+$0.57 (+4.03%)
Volume$2.24M
Capitalization2.02B
HIMS vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
HIMS vs. PRGO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Buy and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (HIMS: $24.40 vs. PRGO: $14.71)
Brand notoriety: HIMS and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HIMS: 210% vs. PRGO: 66%
Market capitalization -- HIMS: $5.55B vs. PRGO: $2.02B
HIMS [@Pharmaceuticals: Generic] is valued at $5.55B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.02B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIMS’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • HIMS’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than HIMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIMS’s TA Score shows that 3 TA indicator(s) are bullish while PRGO’s TA Score has 6 bullish TA indicator(s).

  • HIMS’s TA Score: 3 bullish, 4 bearish.
  • PRGO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than HIMS.

Price Growth

HIMS (@Pharmaceuticals: Generic) experienced а -14.89% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +5.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.57%. For the same industry, the average monthly price growth was -1.57%, and the average quarterly price growth was +13.49%.

Reported Earning Dates

HIMS is expected to report earnings on Feb 23, 2026.

PRGO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.57% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HIMS($5.56B) has a higher market cap than PRGO($2.02B). PRGO has higher P/E ratio than HIMS: PRGO (2818.00) vs HIMS (46.04). PRGO YTD gains are higher at: 5.675 vs. HIMS (-24.854). PRGO has higher annual earnings (EBITDA): 598M vs. HIMS (157M). HIMS has more cash in the bank: 630M vs. PRGO (432M). HIMS has less debt than PRGO: HIMS (1.12B) vs PRGO (3.65B). PRGO has higher revenues than HIMS: PRGO (4.28B) vs HIMS (2.21B).
HIMSPRGOHIMS / PRGO
Capitalization5.56B2.02B274%
EBITDA157M598M26%
Gain YTD-24.8545.675-438%
P/E Ratio46.042818.002%
Revenue2.21B4.28B52%
Total Cash630M432M146%
Total Debt1.12B3.65B31%
FUNDAMENTALS RATINGS
HIMS vs PRGO: Fundamental Ratings
HIMS
PRGO
OUTLOOK RATING
1..100
5476
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
3690
PRICE GROWTH RATING
1..100
9164
P/E GROWTH RATING
1..100
942
SEASONALITY SCORE
1..100
n/a23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for HIMS (82) in the null industry. This means that PRGO’s stock grew somewhat faster than HIMS’s over the last 12 months.

HIMS's Profit vs Risk Rating (85) in the null industry is in the same range as PRGO (100) in the Pharmaceuticals Other industry. This means that HIMS’s stock grew similarly to PRGO’s over the last 12 months.

HIMS's SMR Rating (36) in the null industry is somewhat better than the same rating for PRGO (90) in the Pharmaceuticals Other industry. This means that HIMS’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as HIMS (91) in the null industry. This means that PRGO’s stock grew similarly to HIMS’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for HIMS (94) in the null industry. This means that PRGO’s stock grew significantly faster than HIMS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HIMSPRGO
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 8 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
HIMS
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNVIX39.840.86
+2.21%
Heartland Value Plus Institutional
ICISX15.410.25
+1.65%
VY® Columbia Small Cap Value II I
VEVYX48.710.64
+1.33%
Victory Sycamore Established Value Y
FFANX14.36N/A
N/A
Fidelity Asset Manager 40%
OBMCX53.47-1.17
-2.14%
Oberweis Micro-Cap

HIMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, HIMS has been loosely correlated with PRGO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if HIMS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-4.46%
PRGO - HIMS
55%
Loosely correlated
+4.03%
SXTC - HIMS
55%
Loosely correlated
-13.02%
AKBA - HIMS
51%
Loosely correlated
-2.84%
INCR - HIMS
47%
Loosely correlated
-4.77%
ALVO - HIMS
43%
Loosely correlated
-2.30%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with INCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then INCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+4.03%
INCR - PRGO
56%
Loosely correlated
-4.77%
SHPH - PRGO
54%
Loosely correlated
-12.50%
AKAN - PRGO
51%
Loosely correlated
+0.86%
INM - PRGO
44%
Loosely correlated
-5.66%
SBFM - PRGO
37%
Loosely correlated
-1.63%
More